Cite
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways.
MLA
Wang, Rong, et al. “Emerging Therapeutic Frontiers in Cancer: Insights into Posttranslational Modifications of PD-1/PD-L1 and Regulatory Pathways.” Experimental Hematology & Oncology, vol. 13, no. 1, Apr. 2024, pp. 1–30. EBSCOhost, https://doi.org/10.1186/s40164-024-00515-5.
APA
Wang, R., He, S., Long, J., Wang, Y., Jiang, X., Chen, M., & Wang, J. (2024). Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Experimental Hematology & Oncology, 13(1), 1–30. https://doi.org/10.1186/s40164-024-00515-5
Chicago
Wang, Rong, Shiwei He, Jun Long, Yian Wang, Xianjie Jiang, Mingfen Chen, and Jie Wang. 2024. “Emerging Therapeutic Frontiers in Cancer: Insights into Posttranslational Modifications of PD-1/PD-L1 and Regulatory Pathways.” Experimental Hematology & Oncology 13 (1): 1–30. doi:10.1186/s40164-024-00515-5.